EVOK
Evoke Pharma, Inc.
Set alert
11.00 USD 0.00 0.00%
11.00 Day range 11.00
3.54 52-week range 14.04
- YTD
- +148.87%
- 1 year
- +139.65%
- Open
- 11.00
- Prev close
- 11.00
- Mkt cap
- 7.37M
- Vol
- 47.10K
- Avg vol
- 395.00K
- EPS
- -10.13
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.00
- High
- 11.00
- Forward P/E
- 10.33
- Beta
- 0.35
- Short ratio
- 0.24
- Inst. own
- 17.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.97
- 200-d avg
- 5.60
- 1y target
- 18.00
Key statistics
- Market cap
- 7.37M
- Enterprise value
- 1.20M
- Trailing P/E
- 0.00
- Forward P/E
- 10.33
- PEG ratio
- 0.00
- Price / sales
- 0.86
- Price / book
- 1.01
- EPS (TTM)
- -10.13
- Beta
- 0.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -71.33%
- Revenue (TTM)
- 8.62M
- Revenue growth
- 69.80%
- Free cash flow
- -1.49M
- Total cash
- 11.34M
- Total debt
- 5.00M
- Return on equity
- -349.91%
- Shares outstanding
- 1.49M
- Short % of float
- 1.70%
- 50-day average
- 4.97
- 200-day average
- 5.60
Analyst view
Consensus: none
Price target (mean) 18.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.63.
Financials — quick view
EVOK Revenue — quarterly 4.28M
EVOK Net income — quarterly -1.16M
EVOK EPS — quarterly -0.45
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.94 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.93 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -2.04 | — | — |
| Mar 14, 2024 | Dec 1, 2023 | 0.00 | -7.08 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -6.12 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -6.72 | — | — |
About Evoke Pharma, Inc.
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- evokepharma.com
News
- Gold Falls Over 1%; Uber Shares Decline After Q3 Results
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Dow Dips Over 400 Points; Pfizer Earnings Top Estimates
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 5 Healthcare Stocks On Fire This Week
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Earnings Scheduled For March 13, 2025
- Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on EVOK — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AIGH Capital Management LLC | 4.75% | 70,546 | 349.91K | Sep 29, 2024 |
| Bleichroeder LP | 4.63% | 68,750 | 341.00K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 3.79% | 56,249 | 279.00K | Sep 29, 2024 |
| Corsair Capital Management, L.P. | 0.79% | 11,667 | 57.87K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.05% | 816 | 4.05K | Sep 29, 2024 |
| Blackrock Inc. | 0.01% | 122 | 605 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.17% | 2,487 | 12.34K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 2,404 | 11.92K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 1,496 | 7.42K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 373 | 1.85K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.00% | 41 | 203 | Oct 30, 2024 |